Philip A Philip Selected Research

Philip A Philip Research Topics

Disease

91	Neoplasms (Cancer) 05/2022 - 01/2003
64	Pancreatic Neoplasms (Pancreatic Cancer) 12/2021 - 08/2002
27	Adenocarcinoma 01/2021 - 01/2003
13	Neoplasm Metastasis (Metastasis) 02/2022 - 08/2007
7	Colorectal Neoplasms (Colorectal Cancer) 10/2021 - 02/2008
7	Breast Neoplasms (Breast Cancer) 05/2009 - 11/2002
6	Microsatellite Instability 01/2022 - 01/2018
6	Hepatocellular Carcinoma (Hepatoma) 10/2013 - 02/2009
5	Neuroendocrine Tumors (Neuroendocrine Tumor) 10/2021 - 02/2015
5	Stomach Neoplasms (Stomach Cancer) 01/2021 - 02/2003
4	Disease Progression 10/2021 - 10/2012
4	Carcinogenesis 08/2021 - 01/2003
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2022 - 12/2007
3	Primitive Neuroectodermal Tumors (PNET) 10/2021 - 02/2015
3	Turcot syndrome 08/2020 - 01/2018
3	Rectal Neoplasms (Rectal Cancer) 10/2017 - 08/2007
3	Neutropenia 10/2014 - 12/2006
2	Colonic Neoplasms (Colon Cancer) 02/2022 - 10/2017
2	Cholangiocarcinoma 10/2021 - 01/2018
2	Exanthema (Rash) 10/2015 - 07/2006
2	Fatigue 10/2014 - 10/2013
2	Pathologic Processes 12/2013 - 08/2009
2	Liver Neoplasms (Liver Cancer) 05/2012 - 09/2005
2	Squamous Cell Neoplasms (Squamous Cell Cancer) 04/2011 - 07/2004
2	Fibrosis (Cirrhosis) 11/2009 - 08/2003
2	Diarrhea 06/2009 - 07/2006

Drug/Important Bio-Agent (IBA)

36	Gemcitabine FDA Link 10/2021 - 07/2003
20	MicroRNAs (MicroRNA)IBA 06/2021 - 04/2008
13	ErbB Receptors (EGF Receptor)IBA 10/2015 - 09/2005
12	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2003
11	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2015 - 09/2005
10	NF-kappa B (NF-kB)IBA 05/2010 - 05/2004
9	Fluorouracil (Carac)FDA LinkGeneric 01/2019 - 12/2003
8	Pharmaceutical PreparationsIBA 01/2021 - 05/2010
8	IsoflavonesIBA 01/2013 - 05/2004
7	Proteins (Proteins, Gene)FDA Link 05/2022 - 03/2011
6	EnzymesIBA 10/2021 - 05/2003
6	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2019 - 06/2009
6	Capecitabine (Xeloda)FDA Link 08/2012 - 06/2004
6	GenisteinIBA 08/2011 - 05/2004
6	Cisplatin (Platino)FDA LinkGeneric 04/2010 - 12/2003
6	Docetaxel (Taxotere)FDA Link 10/2007 - 05/2004
5	selinexorIBA 05/2022 - 02/2013
5	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2018
5	Irinotecan (Camptosar)FDA LinkGeneric 01/2021 - 02/2008
5	Cetuximab (Erbitux)FDA Link 01/2021 - 08/2010
5	130-nm albumin-bound paclitaxelIBA 03/2020 - 01/2019
5	Leucovorin (Folinic Acid)FDA Link 01/2019 - 04/2007
5	Biological ProductsIBA 10/2015 - 01/2003
5	Tyrosine Kinase InhibitorsIBA 10/2015 - 12/2007
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2013 - 11/2009
5	Celecoxib (Celebrex)FDA Link 08/2012 - 11/2004
5	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 08/2012 - 12/2005
4	RNA (Ribonucleic Acid)IBA 01/2022 - 11/2002
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 03/2011
4	p21-Activated KinasesIBA 10/2021 - 01/2017
4	Bevacizumab (Avastin)FDA Link 01/2019 - 07/2010
4	LigandsIBA 01/2018 - 09/2005
4	CurcuminIBA 01/2016 - 05/2010
4	3,3'-diindolylmethane (diindolylmethane)IBA 01/2013 - 10/2007
4	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 08/2012 - 12/2005
4	Carboplatin (JM8)FDA LinkGeneric 11/2009 - 02/2003
3	B7-H1 AntigenIBA 01/2022 - 01/2019
3	Everolimus FDA Link 10/2021 - 02/2015
3	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 09/2019 - 02/2013
3	ParaffinIBA 11/2018 - 08/2012
3	Formaldehyde (Formol)FDA Link 11/2018 - 08/2012
3	Paclitaxel (Taxol)FDA LinkGeneric 11/2009 - 02/2003
2	Complement System Proteins (Complement)IBA 02/2022 - 01/2017
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2021 - 11/2020
2	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 10/2021 - 01/2019
2	KPT-9274IBA 10/2021 - 11/2019
2	infigratinibIBA 10/2021 - 01/2018
2	NAD (NADH)IBA 10/2021 - 11/2019
2	pembrolizumabIBA 08/2020 - 01/2018
2	TOR Serine-Threonine KinasesIBA 11/2019 - 02/2015
2	folfirinoxIBA 10/2019 - 01/2019
2	KPT-185IBA 09/2019 - 02/2013
2	Exportin 1 ProteinIBA 09/2019 - 10/2017
2	Phosphotransferases (Kinase)IBA 01/2018 - 02/2010
2	ras ProteinsIBA 01/2018 - 01/2012
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 02/2015 - 04/2013
2	Sorafenib (BAY 43-9006)FDA Link 10/2013 - 02/2009
2	Monoclonal AntibodiesIBA 08/2010 - 01/2010
2	thymoquinoneIBA 06/2010 - 01/2010
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 05/2010 - 12/2007
2	MI 319IBA 05/2010 - 04/2010
2	Antineoplastic Agents (Antineoplastics)IBA 02/2010 - 10/2005
2	IsoenzymesIBA 05/2009 - 02/2009

Therapy/Procedure

67	Therapeutics 05/2022 - 08/2002
17	Drug Therapy (Chemotherapy) 10/2021 - 08/2003
9	Radiotherapy 01/2019 - 12/2003
6	Combination Drug Therapy (Combination Chemotherapy) 01/2019 - 02/2003
4	Immunotherapy 01/2022 - 01/2018
3	Oral Administration 05/2022 - 05/2010
2	Adjuvant Chemotherapy 02/2022 - 01/2020
2	Neoadjuvant Therapy 01/2020 - 01/2019
2	Induction Chemotherapy 07/2019 - 08/2003
2	Precision Medicine 01/2015 - 07/2013
2	Mammaplasty (Breast Reconstruction) 05/2009 - 05/2003